Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00664599
Recruitment Status : Completed
First Posted : April 23, 2008
Last Update Posted : April 30, 2008
Hoffmann-La Roche
Information provided by:
Tehran University of Medical Sciences

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2008
  Actual Study Completion Date : January 2008

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 August 18, 2010
September 10, 2010
2 November 19, 2010
December 14, 2010
3 February 20, 2011
March 21, 2011
4 June 2, 2012
July 5, 2012
5 November 4, 2015
December 9, 2015